In cases of GBM, it is frequently detected that the IGF-1R signaling pathway is compromised, which is associated with the accelerated growth and spreading of malignant cells, as well as a heightened ability to withstand chemotherapy and radiation treatments. Here, IGF1R is linked to glioblastoma.